Alzheimer’s Disease Neuropathologic Change in Cognitively Impaired Prostate Cancer Survivors (P1-6.008)
To determine if Alzheimer’s disease neuropathic change (ADNC) is associated with androgen deprivation therapy (ADT) use in prostate cancer survivors with cognitive impairment.
Authors
- Jeffrey Scott Wefel (ORCID: https://orcid.org/0000-0003-3584-023X)
- Aditya Raghunathan (ORCID: https://orcid.org/0000-0001-6198-7441)
- Clifford R. Jack (ORCID: https://orcid.org/0000-0001-7916-622X)
- Jonathan Graff‐Radford (ORCID: https://orcid.org/0000-0003-2770-0691)
- Bryan J. Neth (ORCID: https://orcid.org/0000-0003-2342-0000)
- Daniel S. Childs (ORCID: https://orcid.org/0000-0001-7643-2836)
- Kathryn J. Ruddy (ORCID: https://orcid.org/0000-0001-6298-332X)
- Vijay K. Ramanan (ORCID: https://orcid.org/0000-0001-6591-8734)
- Eva Alden (ORCID: https://orcid.org/0000-0002-0268-1431)
- Prashanthi Vemuri (ORCID: https://orcid.org/0000-0003-4286-0589)
- Ronald Carl Petersen (ORCID: https://orcid.org/0000-0002-8178-6601)
- Hugo Botha (ORCID: https://orcid.org/0000-0003-4390-685X)
- Aivi T. Nguyen (ORCID: https://orcid.org/0000-0003-1809-9451)
- David S. Knopman (ORCID: https://orcid.org/0000-0002-6544-066X)
- Umar Ghaffar (ORCID: https://orcid.org/0000-0001-6789-8052)
- Jeffrey Karnes
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- WinnMed (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000212210
- Primary Topic
- Cancer-related cognitive impairment studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00